GAITHERSBURG, MD -- (Marketwire) -- 10/11/12 -- Cytomedix, Inc. (OTCQX: CMXI) (the "Company"), a leading developer of biologically active regenerative therapies, today announced that its AutoloGel system is featured at two medical conferences this week, the Inaugural Native American Wound Care Conference in Cabazon, CA, and the Diabetic Limb Salvage Conference in Washington D.C.
The AutoloGel System, a device for the production of autologous platelet rich plasma ("PRP") gel, is the only PRP device cleared by the U.S. Food and Drug Administration ("FDA") for use in wound management.
Native American Wound Care Conference
Morongo Casino Resort & Spa, Cabazon, CA, Oct 8 - 9.
•Dr. Laurie Rappl of Cytomedix hosted a discussion of AutoloGel platelet rich plasma (PRP) and the outcomes achieved using a physiologic concentration PRP Gel in chronic wounds of all etiologies. Dr. Rappl demonstrated how to make and apply AutoloGel to a wound. The lecture covered indications, contraindications, appropriate care after application, and expected outcomes including cost comparison scenarios vs.tissue grafting and NPWT.
The Native American Wound Care Conference was developed to address the higher rates of wound-related complications, amputations and diabetes. Approximately 60% of Native Americans die within two years after an amputation caused by inadequately treated wounds. Tribal Representatives and health care professionals will discuss a range of topics including prevention, diagnosis and treatment of wounds; financing, design and construction of wound care facilities; and the importance of lifestyle, traditional medicine, and awareness within the Tribal community.
Diabetic Limb Salvage Conference
JW Marriott, Washington, D.C. Oct 11 - 13.
•Healing Wagner III and IV Wounds Complicated by Arterial Disease Using Platelet-Rich-Plasma Gel: This study was designed to look at evidence-based treatment outcomes in 39 Japanese patients with 40 complex and severe ulcerations in wound care centers who were treated with AutoloGel. The results showed that 83% of severe, complex wounds, including Wagner III and IV wounds in patients with diabetes and moderate to severe arteriosclerotic obliterans (ASO), healed completely. The lead investigator was Dr. Chugo Rinoie, DPM, ABPO, CWS, Chief of Podiatric Surgery, Wound Healing Center, Methodist Hospital of Southern California, Arcadia, California.
Dr. Rinoie, who was attending the meeting, commented, "The results in these patients are very encouraging. This is a complex and very difficult to treat patient population with poor healing prognosis and a high risk of lower extremity amputation (LEA). The use of AutoloGel represents a meaningful improvement in the standard of care."
The Diabetic Limb Salvage Conference provides medical practitioners with the opportunity to learn about the latest research and the most advanced therapies in this field. The meeting format includes didactic lectures, hands-on workshops, specialty symposia, and live surgical case demonstrations for the purpose of providing a live interactive learning experience. More than 60 distinguished faculty members are presenting and approximately 1,200 delegates are expected to attend.
Most Popular Stories
- Social Media Initiatives Should Follow Customers' Lead
- SEO Traffic Lab Celebrate Wins at Digital Marketing Event 'Internet World 2013' in London
- Apple CEO: Offshore Units Not a 'Tax Gimmick'
- U.S. Senate Accuses Apple of Large-scale Tax Avoidance
- Marketo Makes a Mint in IPO: Stock Shoots Up More than 50 Percent
- UTEP Water Recycling Project Wins Venture Titles
- Crude Oil Up, Gasoline Down
- Bieber Booed at Billboard Awards
- Apple Said to Duck Billions in Taxes
- Austin Startup Compare Metrics Raises $3.5 Million for Expansion